This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Enrique S. Miralles, MD; Bibiana Pérez, MD; María Núñez, MD
Madrid, Spain

Antonio Ledo, MD
Servicio de Dermatología Universidad Alcalá de Henares Hospital Ramón y Cajal Ctera Colmenar Km 9.100 28034 Madrid, Spain

Arch Dermatol. 1994;130(6):799-800.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

We read with interest the article by Tur et al¹ in the October 1993 issue of the ARCHIVES. They obtained good response in four patients using low-dose interferon alfa. In 1992, we also used low-dose interferon alfa to treat three patients with classic Kaposi's sarcoma, none of whom obtained any response (Table).

Report of Cases.Case 1.

A 70-year-old man of Mediterranean origin had a 3-year history of brown plaques with a purplish hue on his feet, legs, thighs, arms, hands, and nose. All of the plaques had the histologic features of Kaposi's sarcoma. Pain and edema were present on both legs. He received local radiotherapy on both feet with little response. Interferon alfa-2a (Roferon-A) (9 million U/d) was administered intramuscularly during a 7-month period. Because of leukopenia, the dose was reduced to 9 million U/d for 3 days per week subcutaneously during a 3-month period. Flattening was observed . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?